Upgrade to SI Premium - Free Trial

Tarsus Pharmaceuticals (TARS)

63.72 +2.45 (4.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Achieve Life Sciences adds two board members ahead of drug resubmission June 2, 2026 8:31 AM - StreetInsider Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors June 2, 2026 8:30 AM - Globe NewsWire Tarsus to Participate in Upcoming Investor Conferences May 28, 2026 4:30 PM - StreetInsider Tarsus Pharmaceuticals (TARS) PT Lowered to $97 at Oppenheimer May 20, 2026 10:40 AM - StreetInsider Form SCHEDULE 13G Tarsus Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC May 15, 2026 11:43 AM - SEC Filing Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: Deep Track Capital, LP May 15, 2026 8:47 AM - SEC Filing Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans May 14, 2026 8:30 AM - Globe NewsWire Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: PRUDENTIAL FINANCIAL INC May 8, 2026 11:22 AM - SEC Filing Tarsus to Participate in Upcoming Investor Conferences May 7, 2026 5:00 PM - StreetInsider Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance May 6, 2026 5:16 PM - StreetInsider Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: JENNISON ASSOCIATES LLC May 6, 2026 4:14 PM - SEC Filing Form 10-Q Tarsus Pharmaceuticals, For: Mar 31 May 6, 2026 4:11 PM - SEC Filing Form 8-K Tarsus Pharmaceuticals, For: May 06 May 6, 2026 4:09 PM - SEC Filing Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements May 6, 2026 4:05 PM - StreetInsider Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 April 29, 2026 4:30 PM - StreetInsider Form 4 Tarsus Pharmaceuticals, For: Apr 24 Filed by: PYOTT DAVID E I April 28, 2026 4:24 PM - SEC Filing Form ARS Tarsus Pharmaceuticals, For: Dec 31 April 28, 2026 4:19 PM - SEC Filing Form DEFA14A Tarsus Pharmaceuticals, April 28, 2026 4:13 PM - SEC Filing Form DEF 14A Tarsus Pharmaceuticals, For: Jun 25 April 28, 2026 4:10 PM - SEC Filing Oppenheimer Assumes Tarsus Pharmaceuticals (TARS) at Outperform April 24, 2026 6:15 AM - StreetInsider Tarsus Pharmaceuticals (TARS) PT Lowered to $100 at Mizuho April 23, 2026 9:24 AM - StreetInsider Tarsus begins phase 2 trial of oral Lyme disease prevention drug March 31, 2026 8:30 AM - StreetInsider Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease March 31, 2026 8:30 AM - StreetInsider Form SCHEDULE 13G/A Tarsus Pharmaceuticals, Filed by: VANGUARD GROUP INC March 27, 2026 1:35 PM - SEC Filing Tarsus Pharmaceuticals (TARS) PT Raised to $101 at Mizuho March 25, 2026 1:36 PM - StreetInsider Form 4 Tarsus Pharmaceuticals, For: Mar 20 Filed by: Neervannan Seshadri March 24, 2026 5:06 PM - SEC Filing William Blair on Tarsus Pharmaceuticals (TARS): 'benefits from the large and motivated patient population' March 23, 2026 9:51 AM - StreetInsider Tarsus receives $15M milestone after China approves TP-03 eye treatment March 23, 2026 8:32 AM - StreetInsider TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus March 23, 2026 8:30 AM - StreetInsider Form 144 Tarsus Pharmaceuticals, Filed by: Neervannan Seshadri March 20, 2026 10:39 AM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Whitfield Dianne C. March 19, 2026 7:05 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Wahl Bryan March 19, 2026 7:05 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Neervannan Seshadri March 19, 2026 7:04 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Mottiwala Aziz March 19, 2026 7:04 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Lin Elizabeth Yeu March 19, 2026 7:04 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Farrow Jeffrey S March 19, 2026 7:04 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Azamian Bobak R. March 19, 2026 7:04 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Farrow Jeffrey S March 19, 2026 4:43 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Mottiwala Aziz March 19, 2026 4:38 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Azamian Bobak R. March 19, 2026 4:32 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Whitfield Dianne C. March 19, 2026 4:25 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Wahl Bryan March 19, 2026 4:25 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Neervannan Seshadri March 19, 2026 4:17 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Lin Elizabeth Yeu March 19, 2026 4:15 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Whitfield Dianne C. March 18, 2026 4:34 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Wahl Bryan March 18, 2026 4:19 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Azamian Bobak R. March 18, 2026 4:18 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Neervannan Seshadri March 18, 2026 4:18 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Farrow Jeffrey S March 18, 2026 4:14 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Mottiwala Aziz March 18, 2026 4:14 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Lin Elizabeth Yeu March 18, 2026 4:12 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 16 Filed by: LINK WILLIAM J PHD March 18, 2026 4:11 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Whitfield Dianne C. March 17, 2026 4:41 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Wahl Bryan March 17, 2026 4:39 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Neervannan Seshadri March 17, 2026 4:38 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Mottiwala Aziz March 17, 2026 4:36 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Farrow Jeffrey S March 17, 2026 4:27 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Azamian Bobak R. March 17, 2026 4:25 PM - SEC Filing Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Lin Elizabeth Yeu March 17, 2026 4:20 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Azamian Bobak R. March 17, 2026 4:10 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Neervannan Seshadri March 17, 2026 4:07 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Farrow Jeffrey S March 17, 2026 4:03 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Wahl Bryan March 17, 2026 4:00 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Whitfield Dianne C. March 17, 2026 3:56 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Lin Elizabeth Yeu March 17, 2026 3:47 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Mottiwala Aziz March 17, 2026 3:42 PM - SEC Filing Form 144 Tarsus Pharmaceuticals, Filed by: Azamian Bobak R. March 16, 2026 5:40 PM - SEC Filing Full Article List